Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Tumor Biology

Abstract 4078: Investigating chemoresistance mechanisms in colorectal cancer stem cells

Stacey J. Butler, Lisa Richardson, Nathan Farias and Brenda L. Coomber
Stacey J. Butler
University of Guelph, Guelph, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Richardson
University of Guelph, Guelph, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Farias
University of Guelph, Guelph, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda L. Coomber
University of Guelph, Guelph, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2015-4078 Published August 2015
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA

Abstract

Treatment of advanced colorectal cancer (CRC) is impacted by a lack of selectivity, the development of drug resistance and overall tumour heterogeneity. Cancer stem cells (CSCs) are a subpopulation of tumour cells believed to be responsible for tumour recurrence due to their ability to self-renew, differentiate and evade current treatments. This project explores the responses of CRC CSCs to chemotherapy and aims to identify therapeutic targets of the CSC population. We used serial colonosphere culture to enrich for CSCs from two human CRC cell lines, HCT116 and SW480. Limiting dilution analysis showed that CSC enriched cell lines have significantly higher colonosphere formation ability compared to their respective parental cells. Further characterization of CSC cell lines was performed via qPCR and flow cytometry to determine the expression of colorectal CSC markers. A significant upregulation in CD166 and EpCAM gene expression was seen in HCT-CSC and SW-CSCs compared to parental cell lines. In vitro assays were used to determine cellular responses to three commonly employed chemotherapeutics, 5-fluorouracil, cisplatin and epirubicin. A limiting dilution analysis demonstrated that cells treated with chemotherapy for 48 hours had reduced colonosphere forming potential. Cell viability in response to chemotherapy was analyzed via PrestoBlue assays in both monolayer and 3D culture. CSC and parental cell lines responded similarly in a dose-dependent manner to treatment in monolayer, but CSC colonospheres were more resistant to high doses of chemotherapy than their respective parental cells. ABC transporter expression plays a major role in the development of multi-drug resistance so the expression of ABCB1, ABCC1 and ABCG2 was examined via qPCR. There was a significant upregulation in ABCB1 and ABCG2 in HCT-CSCs compared to HCT-P cells. SW-CSCs also had significant upregulation in ABCB1 compared to SW-P cells. Other resistance mechanisms may also be key targets for therapeutic intervention including the functional CSC marker aldehyde dehydrogenase (ALDH). The detoxification effects of ALDH could have a protective effect against the surges of reactive oxygen species resulting from chemotherapy treatment. The expression of ALDH and ABC transporter genes was also explored in response to chemotherapy. The goal of this project is to elucidate drug resistance mechanisms in colorectal CSCs, in order to target and eradicate the tumour cells responsible for metastases and recurrent disease. Our analysis demonstrates that colorectal CSCs possess heightened protective mechanisms in comparison to other cancer cells originating from the same tumour. Future experiments will further investigate these resistance mechanisms to determine their therapeutic potential.

Note: This abstract was not presented at the meeting.

Citation Format: Stacey J. Butler, Lisa Richardson, Nathan Farias, Brenda L. Coomber. Investigating chemoresistance mechanisms in colorectal cancer stem cells. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4078. doi:10.1158/1538-7445.AM2015-4078

  • ©2015 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 75 (15 Supplement)
August 2015
Volume 75, Issue 15 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 4078: Investigating chemoresistance mechanisms in colorectal cancer stem cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 4078: Investigating chemoresistance mechanisms in colorectal cancer stem cells
Stacey J. Butler, Lisa Richardson, Nathan Farias and Brenda L. Coomber
Cancer Res August 1 2015 (75) (15 Supplement) 4078; DOI: 10.1158/1538-7445.AM2015-4078

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 4078: Investigating chemoresistance mechanisms in colorectal cancer stem cells
Stacey J. Butler, Lisa Richardson, Nathan Farias and Brenda L. Coomber
Cancer Res August 1 2015 (75) (15 Supplement) 4078; DOI: 10.1158/1538-7445.AM2015-4078
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Tumor Biology

  • Abstract SY34-04: Do we need to know what pO2 hypoxia is
  • Abstract SY28-04: Rational incorporation of novel agents into multimodality treatment of glioma and neuroblastoma
  • Abstract SY28-02: Connections in the BRCA1-BRCA2 pathway of homologous recombination: Implications for breast cancer development and treatment
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Cancer Stem Cells 2

  • Abstract 4077: Adipose-derived stem cells after Paclitaxel treatment demonstrate decreased function and suppression of breast cancer cell viability
  • Abstract 4079: Role of HPVE6 oncoprotein in the maintenance of cervical cancer stem cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement